Attend free virtual event on MRI-guided radiation therapy for pancreatic cancer

Tuesday, June 4, 2024

Providence Cancer Institute is partnering with the Pancreatic Cancer Action Network (PanCAN) for a free virtual patient education event.

MRI-Guided Radiation Therapy and Pancreatic Cancer

Featured speaker: Amar J. Srivastava, M.D., MPH, radiation oncologist
Providence Cancer Institute and The Oregon Clinic
When: Thursday, June 27, 2024, 5:30 - 7:00 p. m.

Register here

Everyone is invited to attend this important talk about MRI-guided radiation therapy and how it's used to treat pancreatic cancer. Providence was the first facility in the Pacific Northwest to offer the technology – the biggest advancement in radiation oncology in over two decades.

Unlike standard radiotherapy, MRI-guided radiation therapy allows radiation oncologists to precisely target and track a tumor. Physicians see in real time if a patient’s tumor has shifted due to movement from the bowels, regular breathing or a heartbeat. The precision and tracking ability of this technology helps reduce the effects of radiation on healthy tissue.

Hear Dr. Srivastava explain the benefits of MRI-guided radiation treatments:

About Amar J. Srivastava, M.D.

Dr. Srivastava was first introduced to the field of radiation oncology when his brother-in-law was diagnosed with a glioblastoma.This experience showed Dr. Srivastava that a cancer diagnosis affects both a patient and their family and it taught him to experience cancer care from the patient's perspective.

Dr. Srivastava was trained in magnetic resonance-guided radiation therapy (MRgRT) during his residency, and he's trained in MR-based adaptive radiotherapy, which is offered by The Oregon Clinic Radiation Oncology in partnership with Providence Cancer Institute. Dr. Srivastava also brings extensive training in gynecologic and genitourinary high-dose rate brachytherapy, which is used to treat cervical/endometrial cancers and prostate cancers.

Learn more about MRI-Guided Radiation Therapy at Providence Cancer Institute.

Targeted therapies are the focus of new studies for colorectal and bile duct cancers

MRI-guided radiotherapy is a gamechanger in treating prostate cancer